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Abstract: The volume-regulated anion channel (VRAC) plays an important role in osmotic cell volume
regulation. In addition, it is involved in various physiological processes such as insulin secretion,
glia-neuron communication and purinergic signaling. VRAC is formed by hetero-hexamers of
members of the LRRC8 protein family, which consists of five members, LRRC8A-E. LRRC8A
is an essential subunit for physiological functionality of VRAC. Its obligate heteromerization
with at least one of its paralogues, LRRC8B-E, determines the biophysical properties of VRAC.
Moreover, the subunit composition is of physiological relevance as it largely influences the activation
mechanism and especially the substrate selectivity. However, the endogenous tissue-specific subunit
composition of VRAC is unknown. We have now developed and applied a quantitative immunoblot
study of the five VRAC LRRC8 subunits in various mouse cell lines and tissues, using recombinant
protein for signal calibration. We found tissue-specific expression patterns of the subunits, and
generally relative low expression of the essential LRRC8A subunit. Immunoprecipitation of LRRC8A
also co-precipitates an excess of the other subunits, suggesting that non-LRRC8A subunits present
the majority in hetero-hexamers. With this, we can estimate that in the tested cell lines, the number of
VRAC channels per cell is in the order of 10,000, which is in agreement with earlier calculations from
the comparison of single-channel and whole-cell currents.
Keywords: volume-regulated anion channel VRAC; volume-sensitive organic outward rectifying
channel VSOR; leucine-rich repeat-containing; anion channel; subunit stoichiometry; heteromeric
complex; tissue-specific protein expression; recombinant protein
1. Introduction
Cells exploit various channels and transporters for inorganic ions and organic osmolytes to
osmotically adjust their volume according to their physiological needs [1,2]. The volume-regulated
anion channel (VRAC) is critically involved in regulatory volume decrease (RVD) upon
hypotonicity-induced swelling of vertebrate cells and during various physiological processes [3].
VRAC is activated by cell swelling or other, isovolumic triggers through an unknown activation
mechanism and conducts Cl- and numerous organic solutes [2–5]. Their eﬄux is followed by
water, leading to cell shrinkage. VRAC-mediated volume decrease plays also a role during early
apoptosis [6,7], debatably during cell migration [8,9], and possibly during spermatogenesis [10].
In addition, membrane depolarization by VRAC-mediated Cl- eﬄux upon glucose-induced cell
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swelling contributes to insulin secretion in pancreatic β-cells [11–13] and VRAC is involved in
membrane potential alterations during myogenic differentiation [14]. Furthermore, VRAC participates
in intercellular communication by conducting signaling molecules. Its adenosine triphosphate (ATP)
permeability links it to purinergic signaling [15,16]. The conductance of excitatory amino acids
such as glutamate is involved in astrocyte-neuron communication and excitotoxicity under ischemic
conditions [17,18]. Besides physiological cargo, VRAC was also shown to at least partly mediate the
cellular uptake of anti-cancer drugs such as cisplatin and of antibiotics such as blasticidin S [7,19].
After a long quest for the molecular identity of VRAC [20,21], the channel was found to be formed
by heteromers of leucine-rich repeat-containing family 8 (LRRC8) proteins [22], with LRRC8A being
the only essential subunit [22,23]. When expressed alone, LRRC8A can form anion channels [24,25]
that are potentially regulated by the same cellular signaling [26], but it must heteromerize with at least
one of its paralogues, LRRC8B-E, for physiological functionality [22,24,25,27]. The recently resolved
structures of LRRC8 complexes confirmed the proposed hexameric arrangement of LRRC8 subunits
within VRAC [28–32]. The subunit stoichiometry is variable and changes with the relative expression
levels of the LRRC8 paralogues [27]. By sequential co-immunoprecipitation, it was shown that LRRC8A
can heteromerize with more than one LRRC8 species within a VRAC complex [33]. Thus, a large
number of VRACs with different subunit compositions is conceivable.
While LRRC8A is the only essential VRAC subunit, the other subunit(s) within a VRAC hexamer
influence some biophysical properties such as its single-channel conductance, the extent of rectification
and the kinetics of depolarization-dependent inactivation [22,24,25,34]. Moreover, the subunit
composition of VRAC is of great physiological importance. Firstly, it may influence the activity regulation
of VRAC. VRAC consisting of LRRC8A/E was shown to be activated by the oxidation of intracellular
cysteines, whereas this inhibited LRRC8A/C- and LRRC8A/D-containing VRAC [35]. Secondly, the
substrate specificity of VRAC alters with the subunit composition, as revealed by heterologous
expression of LRRC8 combinations and/or using gene-depleted cells lines. All combinations with
LRRC8A mediate Cl- currents [22,24]. The presence of LRRC8D additionally increases the permeability
to organic osmolytes such as taurine, myoinositol and various amino acids with different charges, as
well as to cisplatin and blasticidin [7,19,33]. Besides LRRC8A/D, LRRC8A/C and LRRC8A/E conduct
aspartate and glutamate as well [33,36], and ATP is conducted by LRRC8A/E [27].
The physiological importance of VRAC is clear from the severe phenotype of mice lacking the
essential LRRC8A subunit, including high embryonic lethality, as well as from several studies
using gene deletion or downregulation of LRRC8A in a cell type-specific manner or in cell
culture [10,12–14,18,37,38]. However, little is known about the specific roles of the other LRRC8 family
members. Mice lacking LRRC8C gained less weight on a high-fat diet [39], which is consistent with the
role of VRAC—and in particular of LRRC8C—in adipocyte differentiation [38,40]. As expected for the
essential subunit, LRRC8A has been detected in all vertebrate tissues analyzed so far. While LRRC8B,
-C and –D show also broad expression patterns, LRRC8E shows the most restricted tissue expression [3].
While there is information about the relative protein levels of a given LRRC8 paralogue between
tissues, relative expression levels of the different subunits within a cell type are only available on
mRNA level [35,36,41], despite the potentially high physiological relevance of the subunit ratio.
Here we describe a method using quantitative immunoblotting to measure the absolute protein
amount and, importantly, the relative protein levels of the different VRAC LRRC8 subunits in a given
cell type or organ. Recombinant expression and purification of glutathion-S-transferase (GST) fusion
proteins with LRRC8 fragments containing the antigen site enabled a calibration of the immunoblot
signals from murine C2C12 myoblasts, 3T3 fibroblasts and various organs. We found that LRRC8A
is present at low levels, suggesting that VRAC complexes may contain only one or very few of this
essential subunit. Our estimation of the number of VRACs per cell being in the magnitude of ~10,000
is in line with a previous calculations from electrophysiological studies.
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2. Results
2.1. Recombinant Expression of LRRC8A-E Fragments
To allow for the calibration of the immunoblot signal with the antibodies against the LRRC8
proteins, we recombinantly expressed and purified glutathion-S-transferase (GST) fusion proteins with
fragments of LRRC8A-E containing the respective peptide sequence against which the antibody was
generated (Table 1). The fragments of LRRC8A and LRRC8B are from an intracellular loop between
transmembrane helices TM1 and TM2, and the fragments of LRRC8C-E represent the intracellularly
localized carboxy-terminal ends of the proteins. Probing of all five recombinant fusion proteins of
the LRRC8 fragments and of an amino-terminal domain of ClC-6 as control by immunoblot with the
antibodies against LRRC8-E confirmed both the specificity of the antibodies as well as the purity of the
recombinant protein (Figure 1).
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Figure 1. Antibody specificity against LRRC8 fragments and purity of recombinant protein. Equal amounts
(10 ng/lane) of purified recombinant glutathion-S-transferase (GST) fusion proteins of LRRC8A-E fragments
(A–E) and of the amino-terminal domain of ClC-6 (C6N) were probed with anti-LRRC8A-E and anti-GST
antibodies. The presented blots are representative for three independent experiments.
Table 1. LRRC8 fragments containing the peptide against which the antibodies were raised (marked in
bold within the protein fragment sequence). Note that the peptides for the generation of anti-LRRC8C,
-D and –E antibodies localize at the extreme carboxy-termini of the proteins.
Target Epitope Peptide LRRC8 Protein Fragment Fused to GST
LRRC8A QRTKSRIEQGIVDRSE [22] EESDPKPAFSKMNGSMDKKSSTVSEDVEATVPMLQRTKSRIEQGIVDRSETGVLDKKEGEQAK
LRRC8B QSLPYPQPGLESPGIESPT [7] LSKSKTLLSTSGGSADIDASKQSLPYPQPGLESPGIESPTSSVLDKKEGEQAK
LRRC8C EDALFETLPSDVREQMKAD [7] FEVLPPELGDCRALKRAGLVVEDALFETLPSDVREQMKAD
LRRC8D LEVKEALNQDVNVPFANGI [7] QCRMLKKSGLVVEDQLFDTLPLEVKEALNQDVNVPFANGI
LRRC8E LYEGLPAEVREKMEEE [22] TLPEELGDCKGLKKSGLLVEDTLYEGLPAEVREKMEEE
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2.2. Absolute Protein Levels of the LRRC8 Paralogues in Murine Cell Lines
To measure the protein amount of endogenous LRRC8A-E in the murine C2C12 myoblasts and
3T3 fibroblast cell lines, we separated 60 µg of whole-cell protein by SDS-PAGE and probed for the five
LRRC8 proteins by immunoblot (Figure 2). Two independently prepared cell lysates for wild-type
cells were tested per immunoblot. Lysate from cells deficient in the LRRC8A subunit served as control
to identify the specific band for LRRC8A. Furthermore, the disruption of LRRC8A was previously
shown to alter the apparent sizes of its LRRC8 paralogues [7] because LRRC8A is required for ER
exit [22] and hence normal glycosylation of LRRC8B-E, as clearly observable for LRRC8C (Figure 2A,B).
Probing our cell lines together with lysate of previously published HCT116 [22] and HEK293 [33] cells,
either wild-type or with all five LRRC8 genes disrupted, provided further evidence for the specificity
of the selected immuno-signals (Figure S1).
In addition to the protein from the cell lines, dilutions of the recombinant proteins ranging from 3
pg to 3 ng were loaded (Figure 2A,B). This allowed for a calibration with a linear fit in the range of the
signal from the endogenous protein per blot (Figure S2; with three independent blots per protein and
cell type) and hence the calculation of the absolute protein amounts for the five LRRC8 paralogues
(Figure 2C,D). Interestingly, in C2C12 cells the amount of the indispensable subunit LRRC8A is
approximately five-fold lower than the levels of LRRC8B, LRRC8C and LRRC8D; and similar to that of
LRRC8E (Figure 2C). In 3T3 cells, LRRC8E is not expressed at detectable levels and the other subunits
are present at similar numbers (Figure 2D).
Next, we wanted to test whether the ratios in protein levels in cell lysates reflect the
subunit stoichiometries in LRRC8 complexes containing LRRC8A, which is a prerequisite for the
functionality of VRAC. To this end, we immuno-precipitated LRRC8A from C2C12 and 3T3 lysates
(Figure 3A,B). LRRC8B-E efficiently co-precipitated with LRRC8A, but not from LRRC8A-deficient
cells. The Na,K-ATPase, tested as negative control, did not co-precipitate with LRRC8A. As for the
assessment of protein amounts in the lysates of C2C12 and 3T3 cells (Figure 2), we included dilutions of
the recombinant proteins to calibrate for the amounts of LRRC8A-E for each immunoblot. The relative
abundance of the LRRC8 paralogues in the precipitate from C2C12 cells (Figure 3C) is very similar
to that of proteins in C2C12 lysate (Figure 2C). For 3T3 cells, LRRC8A was not enriched relatively to
the other subunits, even rather reduced, comparing the relative protein amounts in the precipitate
(Figure 3D) with those in the cell lysate (Figure 2D). These findings are in consistence with a relatively
low abundance of LRRC8A in LRRC8 hetero-hexamers.
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Figure 2. Quantification of LRRC8 protein amounts in murine cell lines. (A,B) Two replicates of
whole-cell protein preparations from wild-type C2C12 (A) and 3T3 (B) cells (WT-1 and WT-2) and from
a LRRC8A-deficient C2C12 and 3T3 line (KO), with 60 µg/lane, were separated by SDS-PAGE. Each blot
was loaded with a dilution of recombinant GST fusion protein to calibrate for the respective antibody
signal. The size of the LRRC8 proteins, as judged from the LRRC8A KO control or from comparison
to data from human cells lacking all five LRRC8 proteins (Figure S1, [7]), is indicated. The blots are
representative for three independent experiments. (C,D) Quantification of LRRC8A-E in C2C12 (C)
and 3T3 ((D) cells from three independent blots with two lysates each. Data represent the mean from
six lysates ± SD. *** p < 0.001, n.s. = not significant, compared with LRRC8A using one-way analysis of
variance (ANOVA) with Bonferroni’s post hoc test.
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Figure 3. Quantification of LRRC8 protein amounts in co-immunoprecipitation with LRRC8A. (A,B)
LRRC8A co-precipitated LRRC8B-E in immunoprecipitations with an LRRC8A antibody from C2C12
(A) and LRRC8B-D from 3T3 cell lysates (B), but not from the respective LRRC8A-deficient cells. The
Na,K-ATPase, tested as negative control, was not co-precipitated. Lysate equivalent to 25% of input
was loaded as reference (input). Each blot for LR C8A-E was loaded with a dilution of recombinant
GST fusion protein to calibrate for the respective antibody signal. (C,D) Quantification of precipitated
LR C8A-E in C2C12 (C) and 3T3 (D) cells, per µg of total protein subjected to the imm noprecipitation.
Data represent mean ± SD from three independent experiments. * p < 0.05, *** p < 0.001, n.s. = not
significant, compared with LRRC8A using one-way ANOVA with Bonferroni’s post hoc test.
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2.3. Expression Analysis in Mouse Tissues
We next assessed LRRC8 protein levels in a subset of mouse tissues. To this end, we separated
lysate from brain, kidney, lung (Figure 4), heart and spleen (Figure 5) containing 60 µg of protein from
two 8-weeks old male mice by SDS-PAGE and included dilutions of the recombinant LRRC8 fragments
to calibrate the antibody signal.
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Figure 4. Quantification of LRRC8 protein amounts in mouse brain, kidney and lung. (A,B,C) Protein
preparations (60 µg/lane) from brain (A), kidney (B) and lung (C) from two 8-weeks old animals were
separated by SDS-PAGE. Each blot was loaded with a dilution of recombinant GST fusion protein to
calibrate for the respective antibody signal. The size of the LRRC8 proteins, as judged from comparison
to published data r data from human cells lacking all five LRRC8 proteins (Figure S1, [7]), is indicated.
The blots are repr sentative for three exp riments. (D,E,F) Quantification of the protein am unts
of LRRC8A-E in brain (D), kidney (E) nd lung (F). Data represent mean from three independent
experiments (six measurement ) ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, n.s. = not significant,
compared with LRRC8A using one-way ANOVA with Bonferroni’s post hoc test.
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preparations (60 µg/lane) from heart (A) and sple n (B) from two 8-we ks old animals were separated
by SDS-PAGE. Each blot was loaded with a dilution of recombinant GST fusion protein to calibrate
for the respective antibody signal. The size of the LRRC8 proteins, as judged from comparison to
published data or data from human cells lacking all five LRRC8 proteins (Figure S1, [7]), is indicated.
The blots are representative for three experiments. (C,D) Quantification of the protein amounts of
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(six measurements) ± SD. *** p < 0.001, n.s. = not significant, compared ith LRRC8A using one-way
ANOVA with Bonferroni’s post hoc test.
As previously reported [10,13,42], the expression profiles of VRAC subunits vary between mouse
tissues. As in C2C12 cells (Figure 2), in none of the tested organs is the essential LRRC8A the most
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abundant subunit. For example, in brain, each of LRRC8B, -C and –D are present two-fourfold
(Figure 4A,D). LRRC8B shows strongest expression in brain (about 0.2 fmol/µg total protein) and
about half the levels in kidney and lung (Figures 4 and 6), while it was undetectable in heart in spleen
(Figures 5 and 6). The highest levels of LRRC8C were found in the heart (Figures 5 and 6) where it
is the most abundant LRRC8 paralogue. LRRC8D, is present at the same magnitude in all organs
(Figures 4–6). LRRC8E was only detected in lung and spleen, where it was present in similar amounts
as LRRC8A (Figures 4 and 5).
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separated by SDS-PAGE, β-actin (not expressed in heart [43]) served as a lo ding control. The size
of th LRRC8 proteins, as judge from the LRRC8A KO control r f co parison to d ta from
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was additionally verified by Ponceau staining after protein transfer and by probing for GM130 and
GAPDH as loading controls for each im unoblot (exa ples sho n).
Immunoblots with the cell lines and organs tested here in direct comparison largely confirmed
the relative expression levels between tissues (Figure 6).
3. Discussion
Her we present a method to quantify the protein levels of the fiv differen LRRC8 VRAC
subunits in cells and tissues by using recombinantly expressed and purified LRRC8 fragments to
calibrate the signal in immunoblots. The LRRC8 fragments fused to GST contained longer amino
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acid stretches flanking the peptide sequence against which the used antibodies were raised to exclude
any steric hindrance due to the GST despite the denaturation. The fragments for LRRC8C, –D and
–E ended with the peptide because it lies at the extreme carboxy-terminus of the respective protein,
whereas the peptides for the LRRC8A and –B antibodies localize to the first intracellular loop of the
respective protein. Using the appropriate dilutions of the recombinant proteins (tested by trial and
error in preliminary experiments), the protein amount in the tested lysate lied within the range of the
dilution which could be linearly fitted. This method clearly has several uncertainties and the absolute
values determined here must be considered with caution, but they will provide a good lead of the true
protein amounts.
Our study does not only allow to compare the expression of a LRRC8 protein between tissues,
but also to compare the expression of all five paralogues within one organ or cell line. This is important
because the subunit composition of VRAC does not only determine various biophysical properties [5],
but also the physiologically relevant substrate selectivity [7,27,33,36] and regulatory mechanisms [35].
As VRAC is formed by heteromeric hexamers and LRRC8A is essential for VRAC function, it is a
striking finding that, except for 3T3 cells, in all tested tissues LRRC8A represents at most one sixth of
the LRRC8 proteins—often even less. Except for 3T3 and spleen, we found at least one other subunit is
present in significantly higher amounts than LRRC8A. On mRNA levels, LRRC8A was previously
shown to be expressed at less than one sixth of all LRRC8 RNA molecules in Jurkat cells [35]. In rat
astrocytes, LRRC8A mRNA was shown to be expressed at equally low levels [41] or at similar levels to
LRRC8B-D [36]. It remained unknown whether the abundance of mRNA would indeed mirror the
protein levels, and these results are in agreement with the protein levels found here. As the subunit
stoichiometry depends on the relative expression levels [27], the relatively low amount of LRRC8A
hints towards a very low number of LRRC8A subunits in a VRAC hexamer. The ratios between LRRC8
proteins in co-precipitation with LRRC8A, where we also found relatively little LRRC8A, corroborate
this notion. A requirement of only few LRRC8A subunits per hexamer may explain the larger currents
when LRRC8A was diluted in LRRC8A/C co-expression [44] and strong suppression of endogenous
VRAC currents by overexpression of LRRC8A [22,23].
It remains to be investigated whether the non-LRRC8A subunits have preferences for certain
interactions or whether they mix randomly depending on abundance. We cannot exclude the presence
of LRRC8 complexes without LRRC8A, which would enable a scenario where LRRC8A—although
present at relatively low levels—could be the major subunit in LRRC8 heteromers. As all of LRRC8B-E
require co-expression with LRRC8A to exit the ER [22], and such complexes would likely be stuck in
ER and may be subject to ER-associated degradation. It has been proposed that ER-resident LRRC8B
without co-expression of LRRC8A is involved in ER calcium dynamics [45], but endogenous LRRC8B
rather localizes to the plasma membrane [46].
Assuming the presence of one LRRC8A per hexameric VRAC, our quantitative immunoblotting
enables an estimation of the number of VRAC complexes per cell since we know the number of cells
used for the protein lysate preparation. With this, we roughly estimate the presence of ~6000 for
3T3 and ~60,000 for C2C12 cells. This is in good agreement with an earlier study that measured
single-channel conductance of VRACS and estimated the expression of ~10,000 functional VRAC
channels per cell in T-lymphocytes [47].
In summary, the method presented here enables the measurement of absolute protein levels
of the five LRRC8 VRAC subunits in various cells and tissues, providing a useful tool for future
studies on tissue-specific roles of VRAC and on the particular functions of the non-LRRC8A subunits.
It will allow further dissection of the physiologically important subunit stoichiometry, e.g. following
immunoprecipitations. An important finding of our study is the relatively low abundance of the
essential LRRC8A subunit, which suggests the presence of only one or two LRRC8A per hexameric
VRAC. The estimated number of VRACs per cells is in agreement with an earlier estimation from an
electrophysiological study.
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4. Materials and Methods
4.1. Cloning, Expression and Purification of Recombinant GST Fusion Proteins
LRRC8 fragment were amplified by PCR with the following primers on genomic DNA purified












The fusion construct of GST with the amino-terminal 80 amino acids of hClC-6 (C6N) has been
reported previously [48].
GST fusion proteins were expressed in E.coli BL21 for 3 h at 37 ◦C after induction with 0.5 mM
IPTG at an OD600 of 0.8–1.0. The bacteria were harvested by centrifugation, resuspended in lysis
buffer (50 mM Tris pH 7.5, 300 mM NaCl, 5% glycerol (v/v), supplemented with complete and AEBSF
(0.5 mg/mL)) and lysed by sonication. Subsequently, Triton X-100 was added to a final concentration of
1% and cell debris was removed by centrifugation (40 min, 19,500× g, 4 ◦C). For GST fusion protein
purification, glutathione sepharose in binding buffer (50 mM Tris pH 7.5, 300 mM NaCl, 5% glycerol
(v/v), 0.1% Triton X-100 (v/v)) was added to the cell lysates and incubated under agitation for 1 h at 4 ◦C.
The sepharose-lysate mix was centrifuged for 5 min at 500× g and 4 ◦C to obtain the flow-through
fraction. The slurry was washed five times with binding buffer supplemented with complete protease
inhibitor cocktail and AEBSF (0.5 mg/mL) and the bound protein was eluted from the sepharose
in elution buffer (50 mM Tris-HCl, 10 mM reduced glutathion, pH 8.0). Protein concentration was
measured with the BCA-assay kit (Thermo Fisher Scientific, Darmstadt, Germany) and proteins were
flash-frozen in liquid nitrogen and stored at −80 ◦C until further use.
4.2. Cell Lines and Generation of Knockout Cell Lines Using the CRISPR/Cas9 Technology
3T3 mouse fibroblast cell line (American Type Culture Collection, Manassas, VA, USA; ATCC
CL-173) and C2C12 mouse skeletal muscle myoblasts (American Type Culture Collection, Manassas,
VA, USA) were kindly provided by P. Knaus, Freie Universität Berlin, Germany. The generation of
the C2C12-deficient cell line (clone 13) was described previously [9]. For disruption of the Lrrc8a
gene by the CRISPR/Cas9 technology in 3T3 cells, the px459-V.2 single plasmid vector was used,
as previously described for C2C12 [9]: Target sgRNAs (5‘-GCCCCGGAAGGAGTCGTTGCAGG-3′)
were cloned into the px459-V.2 vector and transfected into 3T3 cells using Fugene HD transfection
reagent (Promega, Mannheim, Germany). Two days after transfection, the cells were treated with
10 µg/mL puromycine for two days. Subsequently, the cells were allowed to grow in DMEM
medium (PAN-Biotech, Aidenbach, Germany) supplemented with 10% fetal bovine serum (FBS),
100 units/mL penicillin and 100 µg/mL streptomycin without puromycine for three days before
single clone expansion. Monoclonal cell lines were raised and tested for sequence alterations
using target-site-specific PCR primers (5′-CATGTATGTCTCACTACACCTAACTTGTAG-3′ and
5′-CCAGGAAGATGAGGGTGTGCA-3′) on genomic DNA followed by Sanger-sequencing and
Western blot analysis to confirm the knockout of the LRRC8A protein.
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HCT116 and HEK293 cells with CRISPR/Cas9-mediated disruption of all LRRC8 genes,
whose generation was described previously [22,33], were kindly provided by T.J Jentsch, FMP
and MDC Berlin, Germany. The cells were maintained in McCoy’s 5A medium (HCT116; Thermo
Fisher Scientific, Darmstadt, Germany) or DMEM (HEK293) supplemented with 10% FBS at 37 ◦C in a
humidified atmosphere with 5% CO2.
4.3. Preparation of Cell and Tissue Lysates
Cells were scraped on ice, pelleted down at 2000× g for 5 min and resuspended in pre-cooled RIPA
buffer (150mM NaCl, 50mM Tris pH 8.0, 5mM EDTA pH 8.0, 1% NP-40, 0.5% sodium deocycholate,
0.1% SDS) containing proteinase inhibitor cocktail (Roche, Basel, Switzerland), vortexed and incubated
on ice for 30 min with being vortexed every 10 min. The resuspension was finally centrifuged for 10
min at 10,000× g at 4 ◦C, the resulting supernatant was mixed with SDS sample buffer and heated to
95◦ for 5 min. Total protein concentration of the lysate was determined using the Pierce BCA Protein
Assay kit (Thermo Fisher Scientific, Darmstadt, Germany).
To prepare tissue lysates, 8-weeks old male C57BL/6 wild-type mice were sacrificed by cerebral
dislocation. The mouse organs were homogenized with Triple-Pure High Impact Zirconium Beads
with a 1.5 mm diameter in RIPA buffer using a BeadBug 6 Position Homogenizer (Benchmark Scientific,
Edison, USA). To remove cell debris, the samples were centrifuged for 10 min at 1000× g at 4 ◦C
(Heraeus Fresco 21, Thermo Fisher Scientific, Darmstadt, Germany). The supernatant was used as
whole-organ lysate and the protein concentration was determined with the Pierce BCA Protein Assay
kit (Thermo Fisher Scientific).
4.4. SDS-PAGE and Immunoblotting
Recombinant proteins and cell and tissue lysates were separated by 10% SDS-PAGE transferred to
nitrocellulose membranes (Macherey Nagel, Düren, Germany) at 200 mA for 80 min. Membranes were
subsequently blocked with 5%-skim milk-TBS-T (20mM tris pH 7.6150 mM NaCl and 0.02% Tween-20)
for 1 h at room temperature and incubated with the respective primary antibodies overnight at 4 ◦C.
The rabbit antibodies against LRRC8A-E (used at 1µg/mL), kindly provided by T.J Jentsch, FMP and
MDC Berlin, Germany, were described previously [7,22]. For their generation, the epitope peptides
(Table 1) were coupled through N-terminally added cysteines to keyhole limpet hemocyanin and injected
into rabbits. The polyclonal antibodies were affinity-purified from sera with the respective peptides and
their concentrations were determined using the Pierce BCA Protein Assay kit (Thermo Fisher Scientific,
Darmstadt, Germany) [7,22]. The other used primary antibodies were: rabbit anti GST (used at 1µg/mL;
Cell Signaling, Frankfurt am Main, Germany; #5475S); mouse anti Na,K-ATPase α1 (clone C464.6;
1:1000; Merck, Darmstadt, Germany; #05-369); mouse anti β-actin antibody conjugated to HRP (AC-15;
1:10,000; Abcam, Berlin, Germany; #ab49900); mouse anti GM130 (clone 35; 1:300; BD Biosciences,
Heidelberg, Germany; # 610822); rabbit anti GAPDH (1:2500, Cell Signaling; #2118). After washing,
membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000;
Jackson ImmunoResearch laboratories, Ely, UK) for 1 h at room temperature, washed with TBS-T
and developed by enhanced chemiluminescence reagent (HRP juice; PJK GmbH, Kleinblittersdorf,
Germany) and a ChemiSmart 5000 digital imaging system (Vilber-Lourmat, Collègien, France). Proteins
were quantified using Fiji software [49].
4.5. Co-Immunoprecipitation
For co-immunoprecipitation, C2C12 or 3T3 cells were lysed in 300 µL lysis buffer (150 mM NaCl,
50 mM Tris-HCl pH 7.5, 1% NP-40, 0.5% sodium deoxycholate) containing 4 mM Pefabloc (Carl Roth,
Karlsruhe, Germany) and proteinase inhibitor cocktail (Roche, Basel, Switzerland) for 10 min on ice.
After pre-clearing by centrifugation at 14,000 rpm for 10 min at 4 ◦C, the lysate was spun at 30,000× g
for 30 min at 4 ◦C. Total protein concentration was subsequently determined using the Pierce BCA
Protein Assay kit (Thermo Fisher Scientific, Darmstadt, Germany). 15 µg of the LRRC8A antibody was
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added to the cleared lysate containing 2 mg of total protein. After rotation for 1–2 h at 4 ◦C, 50 µL
of Protein A Dynabeads (Thermo Fisher Scientific, Darmstadt, Germany) were added and rotation
continued overnight at 4 ◦C. After four washes with 500 µL wash buffer (as lysis buffer, but 0.1% NP-40
and 0.05% sodium deoxycholate), precipitates were eluted in 100 µL Lämmli sample buffer. Proteins
were separated by SDS-PAGE and analyzed by immunoblot as indicated. Experiments were repeated
three times.
4.6. Calculation of Protein Amounts and Statistical Analysis
For each immunoblot, a calibration curve was generated with the recombinant proteins (Figure S2).
With the signal of the protein of interest in the cell or tissue lysate (quantified using Fiji software [49])
within the linear range of the calibration curve, the amount of LRRC8 protein within 60 µg of total
protein was calculated by multiplying the equivalent value of GST-fusion protein (calculated with the
linear regression of the calibration curve) with the ratio between the molecular weight of the LRRC8
protein (LRRC8A, 100 kDa; LRRC8B, 95 kDa; LRRC8C, 100 kDa; LRRC8D, 110 kDa; LRRC8E, 100 kDa)
and the GST-fusion protein (34 kDa). With the molecular weight, the molar amount per 1 µg total
protein was calculated. Two independent lysates were tested per calibration curve and all experiments
were performed three times, so that the procedure yielded six values per protein and cell type/organ.
To estimate the number of VRACs per cell, the total protein amount was measured in lysate from a
known number of cells.
The quantitative data are presented as mean of the six measurements ± SD. p values were
determined by a one-way analysis of variance (ANOVA) with Bonferroni’s post hoc test. p values are
indicated according to convention: * p < 0.05, ** p < 0.01, *** p < 0.001, n.s. = not significant.
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/20/23/5879/s1.
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